{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T02:31:40Z","timestamp":1782613900244,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.intimp.2023.110923","type":"journal-article","created":{"date-parts":[[2023,9,14]],"date-time":"2023-09-14T09:45:44Z","timestamp":1694684744000},"page":"110923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"PA","title":["Procalcitonin is elevated in severe malaria and is a promising biomarker of severe malaria and multi-organ dysfunction: A cross-sectional study and meta-analysis"],"prefix":"10.1016","volume":"124","author":[{"given":"Rina","family":"Tripathy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidyut K","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya K","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.intimp.2023.110923_b0005","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1210\/jc.2002-021444","article-title":"Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors","volume":"89","author":"Becker","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0010","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12291-013-0326-z","article-title":"Interrelationship between procalcitonin and organ failure in sepsis","volume":"29","author":"Anand","year":"2014","journal-title":"Indian J. Clin. Biochem."},{"issue":"4","key":"10.1016\/j.intimp.2023.110923_b0015","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.62.4.337","article-title":"Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?","volume":"62","author":"Del\u00e8vaux","year":"2003","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2023.110923_b0020","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/319283","article-title":"Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria","volume":"183","author":"Chiwakata","year":"2001","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.intimp.2023.110923_b0025","doi-asserted-by":"crossref","first-page":"e17440","DOI":"10.1371\/journal.pone.0017440","article-title":"Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study","volume":"6","author":"Erdman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110923_b0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/1475-2875-9-255","article-title":"Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria","volume":"9","author":"te Witt","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.intimp.2023.110923_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2875-11-6","article-title":"Copeptin does not accurately predict disease severity in imported malaria","volume":"11","author":"van Wolfswinkel","year":"2012","journal-title":"Malar. J."},{"issue":"11","key":"10.1016\/j.intimp.2023.110923_b0040","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1046\/j.1360-2276.2003.01128.x","article-title":"CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian children","volume":"8","author":"Braun","year":"2003","journal-title":"Tropical medicine & international health : TM & IH"},{"issue":"6","key":"10.1016\/j.intimp.2023.110923_b0045","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4269\/ajtmh.1998.59.860","article-title":"Serum procalcitonin levels in severe Plasmodium falciparum malaria","volume":"59","author":"Hollenstein","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"2","key":"10.1016\/j.intimp.2023.110923_b0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tmaid.2005.04.003","article-title":"Serum procalcitonin in uncomplicated falciparum malaria: a preliminary study","volume":"4","author":"Uzzan","year":"2006","journal-title":"Travel Med. Infect. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.110923_b0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4097\/kjae.2018.71.2.103","article-title":"Introduction to systematic review and meta-analysis","volume":"71","author":"Ahn","year":"2018","journal-title":"Korean J. Anesthesiol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0060","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/21505594.2022.2056966","article-title":"The spectrum of clinical biomarkers in severe malaria and new avenues for exploration","volume":"13","author":"Foko","year":"2022","journal-title":"Virulence"},{"issue":"2","key":"10.1016\/j.intimp.2023.110923_b0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1515\/ap-2016-0055","article-title":"Determination of PCT on admission is a useful tool for the assessment of disease severity in travelers with imported Plasmodium falciparum malaria","volume":"61","author":"Righi","year":"2016","journal-title":"Acta Parasitol."},{"issue":"37","key":"10.1016\/j.intimp.2023.110923_b0070","first-page":"2933","article-title":"Correlation analysis between lactic, procalcitonin and disease severity in patients with imported malaria from Africa","volume":"102","author":"Du","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.intimp.2023.110923_b0075","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fmicb.2015.00778","article-title":"MBL-2 polymorphisms (codon 54 and Y-221X) and low MBL levels are associated with susceptibility to multi organ dysfunction in P. falciparum malaria in Odisha, India","volume":"6","author":"Das","year":"2015","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.intimp.2023.110923_b0080","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.meegid.2016.04.035","article-title":"Heterozygous mutants of TIRAP (S180L) polymorphism protect adult patients with Plasmodium falciparum infection against severe disease and mortality","volume":"43","author":"Panda","year":"2016","journal-title":"Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases"},{"issue":"11","key":"10.1016\/j.intimp.2023.110923_b0085","doi-asserted-by":"crossref","first-page":"e49420","DOI":"10.1371\/journal.pone.0049420","article-title":"Complement receptor 1 variants confer protection from severe malaria in Odisha, India","volume":"7","author":"Panda","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110923_b0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/1475-2875-10-309","article-title":"Association of ABO blood group with severe falciparum malaria in adults: case control study and meta-analysis","volume":"10","author":"Panda","year":"2011","journal-title":"Malar. J."},{"issue":"2","key":"10.1016\/j.intimp.2023.110923_b0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.actatropica.2012.04.001","article-title":"Bacteraemia in adult patients presenting with malaria in India","volume":"123","author":"Pattanaik","year":"2012","journal-title":"Acta Trop."},{"key":"10.1016\/j.intimp.2023.110923_b0100","unstructured":"G.A. Wells, B. Shea, D. O\u2019Connell, J. Peterson, V. Welch, M. Losos, P. Tugwell, The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, Oxford, 2000."},{"key":"10.1016\/j.intimp.2023.110923_b0105","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"issue":"7109","key":"10.1016\/j.intimp.2023.110923_b0110","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.intimp.2023.110923_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/1469-0691.12494","article-title":"The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses","volume":"20","author":"Melsen","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0120","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.intimp.2023.110923_b0125","first-page":"1588","article-title":"Imported falciparum malaria in adults: host-and parasite-related factors associated with severity","volume":"42","author":"Bruneel","year":"2016","journal-title":"The French prospective multicenter PALUREA cohort study, Intensive care medicine"},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0130","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40794-022-00163-9","article-title":"Procalcitonin levels in children affected by severe malaria compared to those with uncomplicated malaria in the absence of bacterial infection: a cross-sectional study, Tropical Diseases","volume":"8","author":"Katte","year":"2022","journal-title":"Travel Medicine and Vaccines"},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-13-155","article-title":"Evidence for significant influence of host immunity on changes in differential blood count during malaria","volume":"13","author":"Berens-Riha","year":"2014","journal-title":"Malar. J."},{"issue":"6","key":"10.1016\/j.intimp.2023.110923_b0140","doi-asserted-by":"crossref","first-page":"e0233913","DOI":"10.1371\/journal.pone.0233913","article-title":"Reduction in total leukocytes in malaria patients compared to febrile controls: A systematic review and meta-analysis","volume":"15","author":"Kotepui","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2023.110923_b0145","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/796182","article-title":"Leukogram profile and clinical status in vivax and falciparum malaria patients from Colombia","volume":"2015","author":"Tob\u00f3n-Casta\u00f1o","year":"2015","journal-title":"J. Trop. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12639-012-0208-y","article-title":"Clinical profile of severe malaria: study from a tertiary care center in north India","volume":"38","author":"Nandwani","year":"2014","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.intimp.2023.110923_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/5725634","article-title":"Malaria, moderate to severe anaemia, and malarial anaemia in children at presentation to hospital in the Mount Cameroon area: a cross-sectional study","volume":"2016","author":"Sumbele","year":"2016","journal-title":"Anemia"},{"key":"10.1016\/j.intimp.2023.110923_b0160","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2875-2-34","article-title":"Procalcitonin serum levels in tertian malaria","volume":"2","author":"Manegold","year":"2003","journal-title":"Malar. J."},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0165","doi-asserted-by":"crossref","first-page":"11752","DOI":"10.1038\/s41598-019-48182-5","article-title":"TNF-alpha promoter polymorphisms (G-238A and G-308A) are associated with susceptibility to Systemic Lupus Erythematosus (SLE) and P. falciparum malaria: a study in malaria endemic area","volume":"9","author":"Mahto","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2023.110923_b0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1475-2875-5-85","article-title":"Human malarial disease: a consequence of inflammatory cytokine release","volume":"5","author":"Clark","year":"2006","journal-title":"Malar. J."},{"key":"10.1016\/j.intimp.2023.110923_b0175","first-page":"4296523","article-title":"Association between Inflammatory Cytokine Levels and Thrombocytopenia during Plasmodium falciparum and P. vivax Infections in South-Western Coastal Region of India","author":"Punnath","year":"2019","journal-title":"Malaria research and treatment"},{"issue":"1","key":"10.1016\/j.intimp.2023.110923_b0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s40560-017-0246-8","article-title":"Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy","volume":"5","author":"Vijayan","year":"2017","journal-title":"J. Intensive Care"},{"issue":"6","key":"10.1016\/j.intimp.2023.110923_b0185","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/bja\/aei143","article-title":"Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery","volume":"94","author":"Mokart","year":"2005","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.intimp.2023.110923_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-11-6","article-title":"Copeptin does not accurately predict disease severity in imported malaria","volume":"11","author":"van Wolfswinkel","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.intimp.2023.110923_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-9-255","article-title":"Neopterin and procalcitonin are suitable biomarkers for exclusion of severe Plasmodium falciparum disease at the initial clinical assessment of travellers with imported malaria","volume":"9","author":"te Witt","year":"2010","journal-title":"Malar. J."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923012481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:07:53Z","timestamp":1761588473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923012481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"alternative-id":["S1567576923012481"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110923","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Procalcitonin is elevated in severe malaria and is a promising biomarker of severe malaria and multi-organ dysfunction: A cross-sectional study and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110923","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110923"}}